Weight Loss Medication Information

 

Update on availability of Wegovy (semaglutide) and Mounjaro (tirzepatide) to support weight loss.

Wegovy is the brand name for semaglutide, a drug which has been licensed and approved by the National Institute for Health and Care Excellence (NICE) for the management of obesity.

Work is now being carried out with specialists across Kent and Medway to allow appropriate referrals to take place.

 

Accessing Mounjaro for weight loss

Mounjaro is the brand name for tirzepatide, a drug which has been licensed and approved by the National Institute for Health and Care Excellence (NICE) for managing overweight and obesity.

Mounjaro will become available only via specialist weight management services. This is to make sure that correct support such as diet and nutritional services are available alongside the medication.

Find out more here.

 

Injectable weight loss drugs, contraception and HRT

Women aged up to 55 taking GLP-1 agonists:

We have been informed by your private prescriber that you are taking weight loss injections. Tirzepatide (Mounjaro) may mean that your contraception pills do not work effectively. If you are using the contraceptive pill, please use condoms for four weeks after each dose change, to avoid an unwanted pregnancy. This does not apply to semaglutide (Ozempic). Please contact the practice if you want to discuss your contraception.

Women taking GLP1 agonists and using oral progestogens (alone, or in combined oral HRT):

We have been informed by your private provider that you are using weight loss injections. These may have an impact on the effectiveness of your HRT to adequately protect your endometrium (womb lining). Please do contact the practice for a review so that we can discuss potential alternatives.

Published: Jun 2, 2025